NT Shen, A Maw, LL Tmanova, A Pino, K Ancy… - Gastroenterology, 2017 - Elsevier
Background & Aims Systematic reviews have provided evidence for the efficacy of probiotics in preventing Clostridium difficile infection (CDI), but guidelines do not recommend probiotic …
LM Napolitano, CE Edmiston Jr - Surgery, 2017 - Elsevier
Clostridium difficile infections are the leading cause of health care–associated infectious diarrhea, posing a significant risk for both medical and surgical patients. Because of the …
A Ofosu - Annals of gastroenterology: quarterly publication of the …, 2016 - ncbi.nlm.nih.gov
Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare- associated infections in US hospitals. The epidemic strain NAP1/BI/ribotype 027 accounts …
Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare- associated infection and significant source of potentially preventable morbidity, recurrence …
LV McFarland, N Ship, J Auclair, M Millette - Journal of Hospital Infection, 2018 - Elsevier
Clostridium difficile infection (CDI) has become the leading healthcare-associated infection and cause of outbreaks around the world. Although various innovative treatments have been …
IK Louh, WG Greendyke, EA Hermann… - infection control & …, 2017 - cambridge.org
OBJECTIVEPrevention of Clostridium difficile infection (CDI) in acute-care hospitals is a priority for hospitals and clinicians. We performed a qualitative systematic review to update …
E Balsells, T Filipescu, MH Kyaw, C Wiuff… - Journal of global …, 2016 - ncbi.nlm.nih.gov
Background Clostridium difficile is the leading cause of health care–associated infections. Given the high incidence of C. difficile infection (CDI) and the lack of primary prevention …
C Alberda, S Marcushamer, T Hewer, N Journault… - Nutrients, 2018 - mdpi.com
Background: Over 70% of patients are prescribed antibiotics during their intensive care (ICU) admission. The gut microbiome is dramatically altered early in an ICU stay, increasing …
L Fisher, A Fisher - Clinical drug investigation, 2017 - Springer
This narrative review summarises the benefits, risks and appropriate use of acid- suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …